Zogenix reported $106.14M in Cash and Equivalent for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Cash And Equivalent Change
Acadia Pharmaceuticals ACAD:US $ 94.64M 172.32M
Adamas Pharmaceuticals ADMS:US 78.62M 10.17M
Aerie Pharmaceuticals AERI:US $ 61.85M 18.11M
Alnylam Pharmaceuticals ALNY:US $ 1093.99M 348.22M
Arena Pharmaceuticals ARNA:US $ 386.65M 127.52M
AstraZeneca AZN:LN 7067M 8500M
Becton, Dickinson and BDX:US $ 2283M 870M
Biocryst Pharmaceuticals BCRX:US $ 199.6M 10.72M
Biogen BIIB:US $ 1541.8M 200.2M
Cardinal Health CAH:US 2.46B 944M
Esperion Therapeutics ESPR:US $ 103.67M 115.51M
Flexion Therapeutics FLXN:US $ 136.82M 29.2M
GlaxoSmithKline GSK:LN 3453M 50M
Gw Pharmaceuticals GWPH:US $ 458.1M 28.65M
Heron Therapeutics HRTX:US $ 159.57M 31.6M
Intra Cellular Therapies ITCI:US $ 106.13M 14.9M
Marinus Pharmaceuticals MRNS:US $ 145.1M 32.61M
Nektar Therapeutics NKTR:US $ 54.02M 98.33M
Neurocrine Biosciences NBIX:US $ 311.1M 56.9M
Revance Therapeutics RVNC:US $ 127.18M 40.46M
Sarepta Therapeutics SRPT:US $ 1599.11M 98.16M
Teva Pharmaceutical TEVA:IT 2.04B 391M
Zogenix ZGNX:US $ 106.14M 28.81M